BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 35281049)

  • 1. Matrix Remodeling-Associated Protein 8 as a Novel Indicator Contributing to Glioma Immune Response by Regulating Ferroptosis.
    Xu Z; Chen X; Song L; Yuan F; Yan Y
    Front Immunol; 2022; 13():834595. PubMed ID: 35281049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma.
    Cai Y; Liang X; Zhan Z; Zeng Y; Lin J; Xu A; Xue S; Xu W; Chai P; Mao Y; Song Z; Han L; Xiao J; Song Y; Zhang X
    Front Cell Dev Biol; 2021; 9():812422. PubMed ID: 35174170
    [No Abstract]   [Full Text] [Related]  

  • 5. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
    Hu Y; Tu Z; Lei K; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma.
    Mou Y; Zhang L; Liu Z; Song X
    BMC Cancer; 2022 Feb; 22(1):215. PubMed ID: 35227235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remarkable immune and clinical value of novel ferroptosis-related genes in glioma.
    Gao X; Zhao J; Jia L; Zhang Q
    Sci Rep; 2022 Jul; 12(1):12854. PubMed ID: 35896732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma.
    Wang J; Wu N; Feng X; Liang Y; Huang M; Li W; Hou L; Yin C
    Front Immunol; 2022; 13():1052692. PubMed ID: 36685506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
    Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
    Front Neurol; 2022; 13():977180. PubMed ID: 36353126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of six-transmembrane epithelial antigen of prostate 3 promotes the migration and invasion and predicts unfavorable prognosis in glioma.
    Deng L; Zeng S; Yi Q; Song L
    PeerJ; 2023; 11():e15136. PubMed ID: 37009153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma.
    Chen Z; Wu T; Yan Z; Zhang M
    Front Cell Dev Biol; 2021; 9():652599. PubMed ID: 34249910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Ferroptosis-related Gene
    Zhang Z; Qiu X; Yan Y; Liang Q; Cai Y; Peng B; Xu Z; Xia F
    Int J Gen Med; 2021; 14():6189-6200. PubMed ID: 34611432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
    Kong Y; Feng ZC; Zhang YL; Liu XF; Ma Y; Zhao ZM; Huang B; Chen AJ; Zhang D; Thorsen F; Wang J; Yang N; Li XG
    Front Immunol; 2020; 11():1281. PubMed ID: 32765489
    [No Abstract]   [Full Text] [Related]  

  • 14. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Ma W; Zhang K; Bao Z; Jiang T; Zhang Y
    Front Immunol; 2021; 12():659659. PubMed ID: 33936093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Expression of
    Wang Y; Zhao Y; Zhang Z; Zhang J; Xu Q; Zhou X; Mao L
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510310
    [No Abstract]   [Full Text] [Related]  

  • 17. SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in glioma.
    Han L; Zhou J; Li L; Wu X; Shi Y; Cui W; Zhang S; Hu Q; Wang J; Bai H; Liu H; Guo C; Cao H; Chao M; Hu Y; Mou Y; Jiao Y; Feng D; Wang L; Qu Y
    Cell Death Dis; 2022 Dec; 13(12):1071. PubMed ID: 36566214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis Markers Predict the Survival, Immune Infiltration, and Ibrutinib Resistance of Diffuse Large B cell Lymphoma.
    Weng J; Chen L; Liu H; Yang XP; Huang L
    Inflammation; 2022 Jun; 45(3):1146-1161. PubMed ID: 35064379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer.
    Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y
    Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of genomic selection and experimental techniques to predict cell death and immunotherapeutic efficacy of ferroptosis-related CXCL2 in hepatocellular carcinoma.
    Yi Q; Liang Q; Liu Y; Gong Z; Yan Y
    Front Oncol; 2022; 12():998736. PubMed ID: 36276119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.